The medicine man, for the win.
My current biotech holdings consist of NDRM, GILD, AMGN (big pharma), JAZZ, ICPT and I own a few hospital names like LPNT and HCA. I am a man of many hats. But I will tell you, this sector isn’t done going higher.
Just the other day, this industry was down in the dirt, Hybrid score wise (The PPT), and has come back strong since then. At the moment, there is momentum following the space, especially found in stocks like AGIO, BLUE and KITE.
Here are some other names that are down over the past two weeks, that might bounce soon.
ENTA
AKBA
LJPC
BIND
NDRM
CGIX
XENE
Frankly, there’s a lot of them. The names that have been “go to” names in the space are all performing today. I am talking about AGIO, BLUE, KITE, XON, ICPT, MDVN, ACAD, JUNO and GEVA. Perhaps build a basket by combining the two.
Also, with yields on the rise, banks are in play. Remember, when the yield curve steepens, profits at the banks do too. I am eying SBNY, BAC and a small regional bank named CUBI.